{
  "ticker": "VTGN",
  "success": true,
  "price": {
    "current": 0.5412,
    "currency": "USD",
    "day_high": 0.5799,
    "day_low": 0.5351,
    "52_week_high": 5.14,
    "52_week_low": 0.5351
  },
  "market_cap": {
    "value": 21374938.0,
    "currency": "USD"
  },
  "shares_outstanding": 39495451.0,
  "volume": {
    "last": 1838266,
    "average_30d": 1430969
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -0.43999997,
    "price_to_book": 0.3172333
  },
  "company_info": {
    "name": "Vistagen Therapeutics, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 80929000.0,
    "total_liabilities": 14590000.0,
    "stockholders_equity": 66339000.0,
    "cash": 62786000.0,
    "marketable_securities": 14389000.0,
    "total_liquidity": 77175000.0,
    "total_debt": 1865000.0,
    "long_term_debt": 610000.0,
    "current_debt": 658000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": -13759000.0,
    "free_cash_flow": -13819000.0,
    "investing_cash_flow": -94000.0,
    "financing_cash_flow": 27654000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 20311000.0,
    "research_and_development": 15915000.0,
    "interest_expense": null,
    "net_income": -19417000.0,
    "revenue": 258000.0,
    "gross_profit": null,
    "ebitda": -19868000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:52:49.607439",
    "url": "https://finance.yahoo.com/quote/VTGN",
    "data_hash": "a14eae4540777d8a"
  }
}